CRP and cancer: In clinical practice, blood sampling is the easiest and least invasive method of evaluating inflammation, with peripheral serum indicators, such as WBC and CRP, which are considered biomarkers of systemic inflammation, being correlated with prognosis and therapeutic effects in cancer patients.49, 53